Gurion, R., Gafter-Gvili, A., Vidal, L., Leader, A., Ram, R., Shacham-Abulafia, A., Paul, M., Ben-Bassat, I., Shpilberg, O. and Raanani, P. (2012) “Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis”, Haematologica. Pavia, Italy, 98(1), pp. 95-102. doi: 10.3324/haematol.2012.063172.